IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.
about
P2860
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IMproved exercise tolerance in ...... F randomised controlled trial.
@en
IMproved exercise tolerance in ...... F randomised controlled trial.
@nl
type
label
IMproved exercise tolerance in ...... F randomised controlled trial.
@en
IMproved exercise tolerance in ...... F randomised controlled trial.
@nl
prefLabel
IMproved exercise tolerance in ...... F randomised controlled trial.
@en
IMproved exercise tolerance in ...... F randomised controlled trial.
@nl
P2093
P2860
P50
P1433
P1476
IMproved exercise tolerance in ...... F randomised controlled trial.
@en
P2093
Eduard Shantsila
James Fisher
Paramjit S Gill
Ronnie Haynes
P2860
P304
P356
10.1136/BMJOPEN-2016-012241
P577
2016-10-05T00:00:00Z